PHARMACIE DU BOCQ
0832.840.713 · rovalta.com · 25/09/2026
PHARMACIE DU BOCQ
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPHARMACIE DU BOCQ is a Private limited company incorporated in 2011. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Yvoir. It employs on average 2,4 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0832.840.713
- Incorporation
- 17/01/2011
- Legal form
- Private limited company
- Registered office
- Chaussée de Dinant, Spontin 31
5530 Yvoir · WallonieSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 2,4 ETP
Joint committees (2)
- 218
- 313
Financials
Source · NBB, 9 filingsTrend over 9 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 295,5 k € | -4.3% | 308,9 k € | -3.0% | 318,5 k € | +7.1% | 297,3 k € | -10.9% | 333,8 k € |
| EBITDA | 119,4 k € | -18.0% | 145,6 k € | -10.7% | 163,1 k € | -5.6% | 172,7 k € | -17.7% | 209,8 k € |
| Operating result | 35,2 k € | -19.9% | 43,9 k € | -32.2% | 64,8 k € | -16.7% | 77,9 k € | +150% | -156 k € |
| Net result | 4,7 k € | -47.7% | 9 k € | -66.0% | 26,5 k € | -27.7% | 36,6 k € | +117% | -211,5 k € |
| Balance sheet | |||||||||
| Equity | 119,6 k € | -30.3% | 171,5 k € | -19.3% | 212,6 k € | +14.2% | 186,1 k € | +24.5% | 149,5 k € |
| Total assets | 1 M € | -2.2% | 1,1 M € | +1.4% | 1 M € | -8.7% | 1,1 M € | -9.8% | 1,3 M € |
| Cash | 91,2 k € | +208% | 29,6 k € | -32.5% | 43,9 k € | +23.7% | 35,5 k € | -62.8% | 95,3 k € |
| Debts | 907,9 k € | +3.0% | 881,2 k € | +6.1% | 830,4 k € | -13.2% | 956,5 k € | -14.2% | 1,1 M € |
| Other | |||||||||
| Workforce | 2,4 ETP | +4.3% | 2,3 ETP | -4.2% | 2,4 ETP | +4.3% | 2,3 ETP | 0.0% | 2,3 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 14/07/2026 | 30/06/2025 | 01/07/2024 | 05/06/2023 | 08/07/2022 | 20/07/2021 |
| General meeting | 06/06/2026 | 07/06/2025 | 01/06/2024 | 03/06/2023 | 04/06/2022 | 05/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 9 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 06/06/2026 | 14/07/2026 | French | |
| Abridged model | 31/12/2024 | 07/06/2025 | 30/06/2025 | French | |
| Abridged model | 31/12/2023 | 01/06/2024 | 01/07/2024 | French | |
| Abridged model | 31/12/2022 | 03/06/2023 | 05/06/2023 | French | |
| Abridged model | 31/12/2021 | 04/06/2022 | 08/07/2022 | French | |
| Micro model | 31/12/2020 | 05/06/2021 | 20/07/2021 | French | |
| Micro model | 31/12/2019 | 06/06/2020 | 25/08/2020 | French | |
| Micro model | 31/12/2018 | 01/06/2019 | 30/09/2019 | French | |
| Abridged model | 31/12/2017 | 02/06/2018 | 11/06/2018 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Restructuring02/02/2021DENOMINATION - CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring15/12/2020MODIFICATION FORME JURIDIQUE - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...) - DIVERS
- Mandates22/06/2017CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - MODIFICATION FORME JURIDIQUE
- Registered office22/06/2015SIEGE SOCIAL
- Mandates16/02/2015DEMISSIONS, NOMINATIONS
- Other27/01/2011RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20254,7 k €↓
- 2024Annual accounts 20249 k €↓
- 2024Name changeDU BOCQ PHARMACIE
- 2023Annual accounts 202326,5 k €↓
- 2022Annual accounts 202236,6 k €↑
- 2021Annual accounts 2021-211,5 k €↓
- 2021Name changePHARMACIE BOCQ
- 2020Annual accounts 202066,9 k €↓
- 2020Name changePharmacie du Bocq
- 2019Annual accounts 2019104,8 k €↑
- 2018Annual accounts 2018100,6 k €↑
- 2017Annual accounts 20173,6 k €
- 2017Name changeCiRoPhar
- 17/01/2011IncorporationPrivate limited company